Absorption fraction absorbed

The bottoms, consisting of absorption oil, absorbed propane, and higher boiling hydrocarbons, are fed to the lean-oil fractionator. The LPG and the natural gas Hquids are removed as the overhead product from the absorption oil which is removed as a ketde-bottom product. 

Absorption Efficiency, or fraction absorbed Overall tray efficiency, fraction Stripping efficiency, or fraction stripped Fraction of v + li absorbed by the liquid Fraction of loi stripped out of the liquid Mols individual components stripped per hour Total heat of absorption of absorbed components, thousand Btu/day... 

The metabolic and pharmacokinetic profile of sucralose (this is a novel intense sweetener with a potency about 600 times that of sucrose) in human volunteers was studied by Roberts and coworkers [82]. Part of this study was realized using PLC in the following chromatographic system in which the stationary phase was silica gel and the mobile phase was ethyl acetate-methanol-water-concentrated ammonia (60 20 10 2, v/v). Separated substances were scraped off separately, suspended in methanol, and analyzed by filtration, scintillation counting, or enzymatic assay. It was shown that the characteristics of sucralose include poor absorption, rapid elimination, limited conjugative metabolism of the fraction absorbed, and lack of bio-accumulative potential. 

For the majority of drugs, the preferred administration route is by oral ingestion which requires good intestinal absorption of drug molecules. Intestinal absorption is usually expressed as fraction absorbed (FA), expressing the percentage of initial dose appearing in a portal vein [15]. 

The amount of a component absorbed or stripped in a column is dependent on the column design (the number of stages), the component solubility, and the gas and liquid rates. The fraction absorbed can be estimated using the absorption factor method, attributed to Kremser (1930) (see Volume 2, Chapter 12). If the concentration of solute in the solvent feed to the column is zero, or can be neglected, then for the solute component the fraction absorbed =... 

If the areas under the curves are denoted by A, then (based on equal dose) All/Al is the fraction absorbed by oral route. Alll/All is the fraction efficiency of the solid dosage form. The reason for this latter is, of course, that the solid dosage form has to dissolve before the drug contained in it is available for absorption. It is the latter ratio that is important to the investigating pharmaceuticist, and therefore the outcome of the parenteral form is actually not a consideration from a formulation point of view. It is critical overall and if it is low, it may, at the point of parenteral data acquisition, be advisable to stop the program and evaluate the possibility of derivatives that would give better availability. 

Dressman, J. B. Amidon, G. L. Fleisher, D., Absorption potential Estimating the fraction absorbed for orally administered compounds, J. Pharm. Sci. 74, 588-589 (1985). 

Many academic and industrial laboratories have shown that the drug permeability measured in Caco-2 cell monolayers can be used to predict the oral absorption of drugs in humans. Various datasets have therefore been used to establish correlations between Caco-2 permeability and the fraction absorbed orally in humans [85, 86, 96]. Taken together, these studies show good predictability, though with a relatively wide variation in the appearance of correlation profiles between different laboratories [86]. These studies emphasize the need to establish correlations and standardization procedures in each laboratory. 

Fig. 18.2. J-Alert rank correlation for drugs within a J-Alert value on the basis of the affected by active processes during absorption, estimated human effective permeability The ranking of drug molecules on the Y-axis (calculated from a 3D structure by QMPRPIus). was obtained by first sorting the drugs on the The ranking on the X-axis was directly by basis of increasing J-Alert value, and then increasing fraction absorbed value.

It is important to remember that absolute oral bioavailability is a function of both absorption and first-pass metabolism. Therefore, a linear approach to predicting absolute oral bioavailability based on a single parameter, such as rate or extent of absorption (fraction of dose absorbed or estimated dose absorbed) or the rate of metabolism (microsomal or hepatic intrinsic clearance), may result in an inaccu-... 

Data on the absorption of simple salts of the lanthanide elements injected intramuscularly into rats are summarized in Figure 10.4 The dependence of the fraction remaining at the injection site on the administered mass is apparent. When the amount injected was less than 0.01 jug, about 0.5 was absorbed in the first few days another 0.4 was absorbed with a half-time of about 25 days and the remaining 0.1 left the injection site with a half-time of 100 to 200 days. As the total mass injected was increased, the fraction absorbed in the first few days declined, and the amounts associated with the lower absorption rates increased. If 100 jug or more were injected, only 0.05 to 0.1 was absorbed during the first few days, and absorption was very slow thereafter. 

Refinement and expansion of these steady-state mass balance approaches has led to the development of dynamic models which allow for estimation of the fraction absorbed as a function of time and can therefore be used to predict the rate of dmg absorption [37], These compartmental absorption and transit models (CAT) models have subsequently been used to predict pharmacokinetic profiles of drugs on the basis of in vitro dissolution and permeability characteristics and drug transit times in the intestine [38],... 

Lennernas s group at Uppsala has performed extensive studies to confirm the validity of this in vivo experimental set-up at assessing the rate and the extent of drug absorption. Recovery of PEG 4000 (a non-absorbable marker) is more than 95%, which indicates that the absorption barrier is intact. In addition, maintenance of functional viability of the mucosa during perfusion has been demonstrated by the rapid transmucosal transport of D-glucose and L-leucine. Estimation of absorption half-lives from the measured Pefr agree well with half-lives derived from oral dose studies in humans (i.e. physiologically realistic half-lives). Human Peff estimates are well correlated with the fraction absorbed in humans, and served as the basis for BCS development, and hence the technique is ultimately the benchmark by which other in situ intestinal perfusion techniques are compared. The model has been extensively used to... 

A more recent example of this technique has been the study on human absorption characteristics of fexofenadine [109], Fexofenadine has been shown to be a substrate for P-gp in the in vitro cell lines its disposition is altered in knockout mice lacking the gene for MDRla, and co-administration of P-gp inhibitors (e.g. ketoconazole and verapamil) was shown to increase the oral bioavailability of fexofenadine [110-113], Hence, it is suggested that the pharmacokinetics of fexofenadine appears to be determined by P-gp activity. In the human model, the intestinal permeability estimated on the basis of disappearance kinetics from the jejunal segment is low, and the fraction absorbed is estimated to be 2% [114], Co-administration of verapamil/ketoconazole did not affect the intestinal permeability estimates however, an increased extent of absorption (determined by de-convolution) was demonstrated. The increased absorption of fexofenadine was not directly related to inhibition of P-gp-mediated efflux at the apical membrane of intestinal cells as intestinal Peff was unchanged. Furthermore, the effect cannot be explained by inhibition of intestinal based metabolism, as fexofenadine is not metabolised to any major extent. It was suggested that this may reflect modulation of efflux transporters in hepatocyte cells, thereby reducing hepatobiliary extraction of fexofenadine. 

This theory was further explored in an anaesthetised pig model, which facilitated portal vein and bile sampling [86], However, the hepatic extraction ratio and the biliary clearance of fexofenadine were unaffected by verapamil in the pig model. The question as to why verapamil/ketoconazole increase the fraction absorbed (i.e. based on appearance kinetics) and yet the fraction absorbed estimated on the basis of disappearance kinetics (i.e. /err) for the intestinal segment appears unchanged remains to be explored and most likely reflect multiple interplay between absorptive and efflux drug transporters in the intestinal tissue. 

Dressman JB, Amidon GL and Fleisher D (1985) Absorption Potential— Estimating the Fraction Absorbed for Orally-Administered Compounds. J Pharm Sci 74 pp 588-589. 

The hydrogen absorption/desorption kinetics are usually analyzed by applying the JMAK (Johnson-Mehl-Avrami-Kolmogorov) theory of phase transformations, which is based on nucleation and growth events [166-168] where a is the fraction transformed at time t or alternatively for hydrides the fraction absorbed... 

---